BACKGROUND: Androgen receptor (AR) signaling is regarded as the driving force in prostate carcinogenesis, and its modulation represents a logical target for prostate cancer (PC) prevention and treatment. Natural products are the most consistent source of small molecules for drug development. In this study, we investigate the functional impact of piperlongumine (PL), a naturally occurring alkaloid present in the Long pepper (Piper longum), on AR expression in PC cells and delineate its mechanism of action. METHODS: Expression and transcriptional activity of AR was examined by western blotting and luciferase reporter assay, respectively. CellTiter Blue assay was utilized to quantify cell proliferation. Reactive oxygen species (ROS) generation was examined by staining cells with a ROS indicator CM-H(2) DCFDA, followed by flow cytometry analysis. RESULTS: The results of our experiments demonstrate that PL rapidly reduces AR protein levels in PC cells via proteasome-mediated ROS-dependent mechanism. Moreover, PL effectively depletes a modified AR lacking the ligand-binding domain, shedding light on a new paradigm in the treatment approach to prostatic carcinoma that expresses mutated constitutively active AR. Importantly, PL effectively depletes AR in PC cells at low micromolar concentrations, while concurrently exerting a significant inhibitory effect on AR transcriptional activity and proliferation of PC cells. CONCLUSIONS: Our investigation demonstrates for the first time that PL induces rapid depletion of the AR in PC cells. As such, PL may afford novel opportunities for both prevention and treatment of prostatic malignancy.
BACKGROUND:Androgen receptor (AR) signaling is regarded as the driving force in prostate carcinogenesis, and its modulation represents a logical target for prostate cancer (PC) prevention and treatment. Natural products are the most consistent source of small molecules for drug development. In this study, we investigate the functional impact of piperlongumine (PL), a naturally occurring alkaloid present in the Long pepper (Piper longum), on AR expression in PC cells and delineate its mechanism of action. METHODS: Expression and transcriptional activity of AR was examined by western blotting and luciferase reporter assay, respectively. CellTiter Blue assay was utilized to quantify cell proliferation. Reactive oxygen species (ROS) generation was examined by staining cells with a ROS indicator CM-H(2) DCFDA, followed by flow cytometry analysis. RESULTS: The results of our experiments demonstrate that PL rapidly reduces AR protein levels in PC cells via proteasome-mediated ROS-dependent mechanism. Moreover, PL effectively depletes a modified AR lacking the ligand-binding domain, shedding light on a new paradigm in the treatment approach to prostatic carcinoma that expresses mutated constitutively active AR. Importantly, PL effectively depletes AR in PC cells at low micromolar concentrations, while concurrently exerting a significant inhibitory effect on AR transcriptional activity and proliferation of PC cells. CONCLUSIONS: Our investigation demonstrates for the first time that PL induces rapid depletion of the AR in PC cells. As such, PL may afford novel opportunities for both prevention and treatment of prostatic malignancy.
Authors: Konstantin Golovine; Peter Makhov; Robert G Uzzo; Tavis Shaw; David Kunkle; Vladimir M Kolenko Journal: Clin Cancer Res Date: 2008-09-01 Impact factor: 12.531
Authors: Keunho Kim; Tae Gen Son; So Jung Kim; Hyung Sik Kim; Tae Sung Kim; Soon Young Han; Jaewon Lee Journal: J Toxicol Environ Health A Date: 2007-08
Authors: Daniel P Bezerra; Cláudia Pessoa; Manoel Odorico de Moraes; Nylane M N de Alencar; Rodney O Mesquita; Michael W Lima; Ana Paula N N Alves; Otília Deusdênia L Pessoa; João Henrique Chaves; Edilberto R Silveira; Letícia V Costa-Lotufo Journal: J Appl Toxicol Date: 2008-07 Impact factor: 3.446
Authors: R Bruce Montgomery; Elahe A Mostaghel; Robert Vessella; David L Hess; Thomas F Kalhorn; Celestia S Higano; Lawrence D True; Peter S Nelson Journal: Cancer Res Date: 2008-06-01 Impact factor: 12.701
Authors: Stephen J Libertini; Clifford G Tepper; Veronica Rodriguez; David M Asmuth; Hsing-Jien Kung; Maria Mudryj Journal: Cancer Res Date: 2007-10-01 Impact factor: 12.701
Authors: John M Fitzpatrick; John Anderson; Cora N Sternberg; Neil Fleshner; Karim Fizazi; Xavier Rébillard; Luigi Dogliotti; Giario Conti; Ingela Turesson; Nicholas James; Axel Heidenreich; Eduardo Solsona; Vicente Guillem; Daniel Herchenhorn; Judd Moul; Jeroen van Moorselaar; Lance J E Coetzee; Andrew Wilson; Aristotelis Bamias; Ronald De Wit; Michael Chrisofos Journal: Crit Rev Oncol Hematol Date: 2008-08-23 Impact factor: 6.312
Authors: Yaroslava Karpova; Chao Wu; Ali Divan; Mark E McDonnell; Elizabeth Hewlett; Peter Makhov; John Gordon; Min Ye; Allen B Reitz; Wayne E Childers; Tomasz Skorski; Vladimir Kolenko; Alexei V Tulin Journal: Biochem Pharmacol Date: 2019-03-15 Impact factor: 5.858
Authors: Serge Ginzburg; Konstantin V Golovine; Petr B Makhov; Robert G Uzzo; Alexander Kutikov; Vladimir M Kolenko Journal: Prostate Date: 2013-10-22 Impact factor: 4.104
Authors: Konstantin Golovine; Peter Makhov; Sei Naito; Henish Raiyani; Jeffrey Tomaszewski; Reza Mehrazin; Alexei Tulin; Alexander Kutikov; Robert G Uzzo; Vladimir M Kolenko Journal: Cancer Biol Ther Date: 2015 Impact factor: 4.742
Authors: James L Kirkland; Tamara Tchkonia; Yi Zhu; Laura J Niedernhofer; Paul D Robbins Journal: J Am Geriatr Soc Date: 2017-09-04 Impact factor: 5.562
Authors: Lee Farrand; Ji Young Kim; Akechai Im-Aram; Jeong-Yong Suh; Hyong Joo Lee; Benjamin K Tsang Journal: PLoS One Date: 2013-09-09 Impact factor: 3.240
Authors: P Makhov; K Golovine; E Teper; A Kutikov; R Mehrazin; A Corcoran; A Tulin; R G Uzzo; V M Kolenko Journal: Br J Cancer Date: 2014-01-16 Impact factor: 7.640